Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar;99(3):835-42.
doi: 10.1210/jc.2013-3570. Epub 2014 Jan 1.

Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011

J Bradley Layton  1 , Dongmei Li, Christoph R Meier, Julie L Sharpless, Til Stürmer, Susan S Jick, M Alan Brookhart
Affiliations

Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011

J Bradley Layton et al. J Clin Endocrinol Metab. 2014 Mar.

Abstract

Context: New formulations, increased marketing, and wider recognition of declining testosterone levels in older age may have contributed to wider testosterone testing and supplementation in many countries.

Objective: Our objective was to describe testosterone testing and testosterone treatment in men in the United Kingdom and United States.

Design: This was a retrospective incident user cohort.

Setting: We evaluated commercial and Medicare insurance claims from the United States and general practitioner healthcare records from the United Kingdom for the years 2000 through 2011.

Participants: We identified 410,019 US men and 6858 UK men who initiated a testosterone formulation as well as 1,114,329 US men and 66,140 UK men with a new testosterone laboratory measurement.

Main outcome measures: Outcome measures included initiation of any injected testosterone, implanted testosterone pellets, or prescribed transdermal or oral testosterone formulation.

Results: Testosterone testing and supplementation have increased pronouncedly in the United States. Increased testing in the United Kingdom has identified more men with low levels, yet US testing has increased among men with normal levels. Men in the United States tend to initiate at normal levels more often than in the United Kingdom, and many men initiate testosterone without recent testing. Gels have become the most common initial treatment in both countries.

Conclusions: Testosterone testing and use has increased over the past decade, particularly in the United States, with dramatic shifts from injections to gels. Substantial use is seen in men without recent testing and in US men with normal levels. Given widening use despite safety and efficacy questions, prescribers must consider the medical necessity of testosterone before initiation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Cohort schematics. A, Testosterone testing cohort. B, Testosterone initiation cohort.
Figure 2.
Figure 2.
Trends of testosterone laboratory testing (A) and initiation (B) in the United States and United Kingdom, 2000 to 2011.
Figure 3.
Figure 3.
Serum total testosterone laboratory test results by year among newly tested non-testosterone users in the United Kingdom (A) and United States (B).
Figure 4.
Figure 4.
The 90-day initiation of testosterone rates by baseline testosterone level in the United Kingdom (A) and United States (B).
Figure 5.
Figure 5.
Initial formulation in testosterone initiators.
See this image and copyright information in PMC

Comment in

References

    1. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:2536–2559 - PubMed
    1. Travison TG, Araujo AB, Hall SA, McKinlay JB. Temporal trends in testosterone levels and treatment in older men. Curr Opin Endocrinol Diabetes Obes. 2009;16:211–217 - PubMed
    1. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86:724–731 - PubMed
    1. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87:589–598 - PubMed
    1. Wu FC, Tajar A, Pye SR, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008;93:2737–2745 - PubMed

Publication types